KennethVLiebermanMD

Pediatric Chronic Renal Failure and Dialysis, Pediatric Fluid and Electrolyte Disorder Nephrology, Pediatric Glomerular Disease Nephrology, Pediatric Kidney Transplantation Medicine

Professor of Pediatrics, Hackensack Meridian School of Medicine at Seton Hall University

Join to view full profile

Dr. Lieberman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lieberman's full profile

Already have an account?

Office
30 Prospect Ave
# Humc
Hackensack, NJ 07601
Phone+1 551-996-8228

Fax+1 551-996-5397

Summary

Dr. Kenneth Lieberman is a pediatric nephrologist in Hackensack, NJ and is affiliated with multiple hospitals in the area, including Hackensack Meridian Health Hackensack University Medical Center, St. Joseph's University Medical Center, Morristown Medical Center, Joseph Sanzari Children’s Hospital, Hackensack Meridian Health Palisades Medical Center, and Hackensack Meridian Health Jersey Shore University Medical Center. He received his medical degree from Albert Einstein College of Medicine and has been in practice 40 years. He specializes in pediatric chronic renal failure and dialysis, pediatric fluid and electrolyte disorder nephrology, pediatric glomerular disease nephrology, and pediatric kidney transplantation medicine and is experienced in chronic kidney disease, end-stage renal disease, glomerular disease, acute pyelonephritis, and kidney transplantation.

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Nephrology, 1979 - 1981
Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 1977 - 1979
Albert Einstein College of MedicineClass of 1977
Princeton UniversityBSE, Computer Science, 1969 - 1973

Certifications & Licensure

NJ State Medical License 2001 - 2025
NY State Medical License 1978 - 2010
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Nephrology

Awards, Honors, & Recognition

Inside Jersey - Top Doctors for Children Castle Connolly, 2010-2014
Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
New York Magazine: Top Doctors Castle Connolly, 2002-2011, 2013
New Jersey Life:Top Pediatric Specialists Castle Connolly, 2005
New Jersey Life: Top Doctors Castle Connolly, 2005
New Jersey Monthly: Top Doctors Castle Connolly, 2003, 2005
New York Magazine: Top Pediatricians Castle Connolly, 2003
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease Start of enrollment: 2006 Jan 01
Completed
Not Applicable
Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis Start of enrollment: 2014 Mar 01
Completed
Phase 2
A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia Start of enrollment: 2016 May 26
Terminated
Phase 3
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Start of enrollment: 2017 Mar 02
Completed
Phase 2, Phase 3
Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS) Start of enrollment: 2017 Aug 31
Completed
Phase 3
Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS) Start of enrollment: 2018 Apr 17
Active, not recruiting
Phase 3
An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) Start of enrollment: 2019 Mar 08
Terminated
Phase 3
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia Start of enrollment: 2019 Apr 02
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

17 citations
Characteristics of social networks in adolescents with end-stage renal disease treated with renal transplantation.
Sanford M. Melzer, Bonnie J. Leadbeater, Lewis Reisman, Leslie R. Jaffe, Kenneth V. Lieberman
Journal of Adolescent Health Care. 1989-07-01
201 citations
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
Larry A. Greenbaum, Marc Fila, Gianluigi Ardissino, Samhar I. Al-Akash, Jonathan R. Evans
Kidney International. 2016-03-01
112 citations
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.
Howard Trachtman, Peter T. Nelson, Sharon G. Adler, Kirk N. Campbell, Abanti Chaudhuri
Journal of the American Society of Nephrology. 2018-11-01

Journal Articles

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
Howard Trachtman, Peter Nelson, Abanti Chaudhuri, Jai Radhakrishnan, Olga Zhdanova, Debbie S Gipson, Tarak Srivastava, Kenneth Lieberman, Vimal Kumar Derebail, Jonatha..., Journal of the American Society of Nephrology

Press Mentions

Hackensack Meridian Children’s Health Pediatric Nephrology Chief Recognized with Excellence in Care AwardMarch 23rd, 2022
Hackensack Meridian Children’s Health Welcomes Pediatric Nephrologist to Lead Pediatric Kidney Transplant Program at Joseph M. Sanzari Children’s HospitalSeptember 16th, 2021
Mysterious COVID Syndrome in Kids Attacks Their Kidneys in About Half the CasesMarch 12th, 2021
Join now to see all